TOWA Pharmaceutical CoTSE:4553 +0.26%85 OCF Margin % is 24.85% as of Mar. 2026, which is 115% above its 10-year median of 11.56. GuruFocus rates TSE:4553 with a GF Score™ of 85/100 and a GF Value™ of 円3,354.32 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 959 Drug Manufacturers companies, TOWA Pharmaceutical Co ranks better than 54.54% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TOWA Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where TOWA Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TOWA Pharmaceutical Co (TSE:4553) has a OCF Margin % of 24.85% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TOWA Pharmaceutical Co and its competitors. This is 115% above median its historical median of 11.56. Over the past decade, TOWA Pharmaceutical Co's OCF Margin % has ranged from 1.22 to 20.58. According to the industry distribution chart, TOWA Pharmaceutical Co ranks #436 out of 959 companies in the Drug Manufacturers industry, placing it in the top 45.5%.
Is TOWA Pharmaceutical Co's OCF Margin % too high?
TOWA Pharmaceutical Co's current OCF Margin % of 24.85% is 115% above median its 10-year median of 11.56. Over the past 10 years, this metric has ranged from a low of 1.22 to a high of 20.58. The Drug Manufacturers industry median OCF Margin % is 9.95. TOWA Pharmaceutical Co's value of 24.85% is 149.7% above this industry median. Based on the distribution chart, TOWA Pharmaceutical Co ranks #436 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, TOWA Pharmaceutical Co has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, TOWA Pharmaceutical Co ranks #436 out of 959 companies for OCF Margin %. This puts TOWA Pharmaceutical Co in the upper half of its industry. The industry median OCF Margin % is 9.95. TOWA Pharmaceutical Co's value of 24.85% is 149.7% above this benchmark. Historically, TOWA Pharmaceutical Co's own OCF Margin % has ranged from 1.22 to 20.58 over the past decade. While the company's 10-year median is 11.56 vs. the industry median of 9.95, TOWA Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TOWA Pharmaceutical Co's current OCF Margin % of 24.85% is 149.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TOWA Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TOWA Pharmaceutical Co's current OCF Margin % is 24.85%, which is 115% above median its own 10-year median of 11.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co (TSE:4553) is currently considered Modestly Overvalued. The stock's GF Value™ is 円3,354.32, compared to a current price of 円3,845.00 — trading 14.6% above its estimated fair value. The current OCF Margin % is 24.85%, which is 115% above median its 10-year median of 11.56 and 149.7% above the Drug Manufacturers industry median of 9.95. TOWA Pharmaceutical Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For TOWA Pharmaceutical Co (TSE:4553), the current OCF Margin % is 24.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TOWA Pharmaceutical Co (TSE:4553) Overvalued in 2026?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円3,845.00 is trading 14.6% above its estimated GF Value™ of 円3,354.32.
GuruFocus considers TOWA Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for TSE:4553:
OCF Margin %: 24.85% (115% above median its 10-year median of 11.56)
GF Value™: 円3,354.32 vs. price of 円3,845.00 (14.6% above fair value)
Industry Position: 149.7% above the Drug Manufacturers median (#436 of 959)
No single metric tells the full story. See the TSE:4553 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
85GF Score
Get the complete analysis for TSE:4553
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4553 has been successfully added to your 
